Skip to main content
. 2023 Jun 13;11:1110903. doi: 10.3389/fpubh.2023.1110903

Table 3.

Susceptibility patterns of ceftriaxone-susceptible Streptococcus pneumoniae (n = 33) and ceftriaxone-non-susceptible S. pneumoniae (n = 56).

Antibiotics Ceftriaxone-susceptible S. pneumoniae (n = 33) Ceftriaxone-non-susceptible S. pneumoniae (n = 56) p-value
S n (%) I n (%) R n (%) S n (%) I n (%) R n (%)
Trimethoprim/ sulfamethoxazole 4 (12.1) 1 (3.0) 28 (84.9) 3 (5.4) 1 (1.8) 52 (92.8) 0.473
Clindamycin 2 (6.1) 0 31 (93.9) 8 (14.3) 0 48 (85.7) 0.235
Erythromycin 0 0 33 (100) 1 (1.8) 2 (3.6) 53 (94.6) 0.401
Clarithromycin 0 1 (3.0) 32 (97.0) 5 (8.9) 4 (7.2) 47 (83.9) 0.137
Chloramphenicol 31 (93.9) 0 2 (6.1) 53 (94.6) 0 3 (5.4) 0.889
Ciprofloxacin 25 (75.8) 1 (3.0) 7 (21.2) 28 (50.0) 5 (8.9) 23 (41.1) 0.048
Levofloxacin 26 (78.8) 2 (6.1) 5 (15.1) 46 (82.1) 2 (3.6) 8 (14.3) 0.850
Vancomycin 41 (100) 0 0 48 (100) 0 0 NA
Linezolid 41 (100) 0 0 48 (100) 0 0 NA

S, susceptible; I, intermediate; R, resistant; NA, not applicable. The bold values mean statistically significant difference (with p < 0.05).